Tilray Brands (TLRY) Cash from Operations Growth (5y) (2024 - 2025)
Tilray Brands (TLRY) Cash from Operations Growth (5y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Tilray Brands | 443.94 Mn | 383.75 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -40.64% |
| Aug 31, 2025 | 52.61% |
| May 31, 2025 | -17.00% |
| May 31, 2024 | 31.73% |